19730 Federal Register / Vol. 80, No. 70 / Monday, April 13, 2015 / Notices 

ACTION: Notice of Intent for Waiver of 

Aeronautical Land-Use. 

SUMMARY: The Federal Aviation 

Administration (FAA) is considering a 

proposal to change a portion of the 

airport from aeronautical use to nonaeronautical use and to authorize the 

conversion of the airport property. The 

proposal consists of three parcels of 

land containing a total of approximately 

240.80 acres located on the east side of 

the airport between South Portland 

Avenue and Interstate Highway 44. 

The parcel 52 was originally acquired 

under the following grant: Airport 

Development Aid Program (ADAP) No. 

6–40–0072–76 in 1975. The parcel 51 

was originally acquired under the 

following grant: Airport Development 

Program (AIP) No. 3–40–0072–23 in 

1992. The parcel 46 was acquired by 

Trust funds only. The land comprising 

these parcels is outside the forecasted 

need for aviation development and, 

thus, is no longer needed for indirect or 

direct aeronautical use. The Airport 

wished to develop this land for 

compatible commercial, nonaeronautical use. The income from the 

conversion of these parcels will benefit 

the aviation community by reinvestment 

in the airport. 

Approval does not constitute a 

commitment by the FAA to financially 

assist in the conversion of the subject 

airport property nor a determination of 

eligibility for grant-in-aid funding from 

the FAA. The disposition of proceeds 

from the conversion of the airport 

property will be in accordance with 

FAA’s policy and Procedures 

Concerning the Use of Airport Revenue, 

published in the Federal Register on 

February 16, 1999. In accordance with 

section 47107(h) of title 49, United 

States Code, this notice is required to be 

published in the Federal Register 30 

days before modifying the land-use 

assurance that requires the property to 

be used for an aeronautical purpose. 

DATES: Comments must be received on 

or before May 13, 2015. 

ADDRESSES: Comments on this 

application may be mailed or delivered 

to the FAA at the following address: Mr. 

Glenn A. Boles, Manager, Federal 

Aviation Administration, Southwest 

Region, Airports Division, AR/OK 

Airports Development Office, ASW– 

630, 2601 Meacham Boulevard, Fort 

Worth, TX 76137. 

FOR FURTHER INFORMATION CONTACT: Mr. 

Mark Kranenburg, Director of Airports, 

The City of Oklahoma City, 7100 

Terminal Drive, Oklahoma City, OK 

73159, telephone (405) 316–3200; or Mr. 

Glenn A. Boles, Federal Aviation 

Administration, Arkansas/Oklahoma 

Airports Development Office Manager, 

2601 Meacham Boulevard, Fort Worth, 

TX 76137, telephone (817) 222–5630, 

FAX (817) 222–5987. Documents 

reflecting this FAA action may be 

reviewed at the above locations. 

Issued in Fort Worth, TX, in March 20, 

2015. 

Ignacio Flores, 

Manager, Airports Division, Southwest 

Region. 

[FR Doc. 2015–08382 Filed 4–10–15; 8:45 am] 

BILLING CODE 4910–13–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[Docket No. FMCSA–2014–0382] 

Qualification of Drivers; Exemption 

Applications; Epilepsy and Seizure 

Disorders 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), DOT. 

ACTION: Notice of applications for 

exemptions; request for comments. 

SUMMARY: FMCSA announces receipt of 

applications from 19 individuals for an 

exemption from the prohibition against 

persons with a clinical diagnosis of 

epilepsy or any other condition that is 

likely to cause a loss of consciousness 

or any loss of ability to operate a 

commercial motor vehicle (CMV) in 

interstate commerce. The regulation and 

the associated advisory criteria 

published in the Code of Federal 

Regulations as the ‘‘Instructions for 

Performing and Recording Physical 

Examinations’’ have resulted in 

numerous drivers being prohibited from 

operating CMVs in interstate commerce 

based on the fact that they have had one 

or more seizures and are taking antiseizure medication, rather than an 

individual analysis of their 

circumstances by a qualified medical 

examiner. If granted, the exemptions 

would enable these individuals who 

have had one or more seizures and are 

taking anti-seizure medication to 

operate CMVs for up to 2 years in 

interstate commerce. 

DATES: Comments must be received on 

or before May 13, 2015. 

ADDRESSES: You may submit comments 

bearing the Federal Docket Management 

System (FDMS) Docket ID FMCSA– 

2014–0382 using any of the following 

methods: 

• Federal eRulemaking Portal: Go to 

www.regulations.gov. Follow the on-line 

instructions for submitting comments. 

• Mail: Docket Management Facility; 

U.S. Department of Transportation, 1200 

New Jersey Avenue SE., West Building 

Ground Floor, Room W12–140, 

Washington, DC 20590–0001. 

• Hand Delivery or Courier: West 

Building Ground Floor, Room W12–140, 

1200 New Jersey Avenue SE., 

Washington, DC, between 9 a.m. and 5 

p.m., Monday through Friday, except 

Federal Holidays. 

• Fax: 1–202–493–2251. 

Each submission must include the 

Agency name and the docket ID for this 

Notice. Note that DOT posts all 

comments received without change to 

www.regulations.gov, including any 

personal information included in a 

comment. Please see the Privacy Act 

heading below. 

Docket: For access to the docket to 

read background documents or 

comments, go to www.regulations.gov, 

at any time or Room W12–140 on the 

ground level of the West Building, 1200 

New Jersey Avenue SE., Washington, 

DC, between 9 a.m. and 5 p.m., Monday 

through Friday, except Federal holidays. 

The FDMS is available 24 hours each 

day, 365 days each year. If you want 

acknowledgment that we received your 

comments, please include a selfaddressed, stamped envelope or 

postcard or print the acknowledgement 

page that appears after submitting 

comments on-line. 

Privacy Act: In accordance with 5 

U.S.C. 553(c), DOT solicits comments 

from the public to better inform its 

rulemaking process. DOT posts these 

comments, without edit, including any 

personal information the commenter 

provides, to www.regulations.gov, as 

described in the system records notice 

(DOT/ALL–14 FDMS), which can be 

reviewed at www.dot.gov/privacy. 

FOR FURTHER INFORMATION CONTACT: 

Charles A. Horan, III, Director, Office of 

Carrier, Driver and Vehicle Safety, (202) 

366–4001, or via email at 

fmcsamedical@dot.gov, or by letter to 

FMCSA, Room W64–113, Department of 

Transportation, 1200 New Jersey 

Avenue SE., Washington, DC 20590– 

0001. Office hours are from 8:30 a.m. to 

5 p.m., Monday through Friday, except 

Federal holidays. 

SUPPLEMENTARY INFORMATION: 

Background 

Under 49 U.S.C. 31315 and 31136(e), 

FMCSA may grant an exemption for up 

to a 2-year period if it finds ‘‘such 

exemption would likely achieve a level 

of safety that is equivalent to or greater 

than the level that would be achieved 

absent such exemption.’’ The statutes 

allow the Agency to renew exemptions 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 80, No. 70 / Monday, April 13, 2015 / Notices 19731 

at the end of the 2-year period. The 19 

individuals listed in this notice have 

requested an exemption from the 

epilepsy prohibition in 49 CFR 

391.41(b)(8), which applies to drivers 

who operate CMVs as defined in 49 CFR 

390.5, in interstate commerce. Section 

391.41(b)(8) states that a person is 

physically qualified to drive a CMV if 

that person has no established medical 

history or clinical diagnosis of epilepsy 

or any other condition which is likely 

to cause the loss of consciousness or any 

loss of ability to control a CMV. 

FMCSA provides medical advisory 

criteria for use by medical examiners in 

determining whether drivers with 

certain medical conditions should be 

certified to operate CMVs in intrastate 

commerce. The advisory criteria 

indicate that if an individual has had a 

sudden episode of a non-epileptic 

seizure or loss of consciousness of 

unknown cause that did not require 

anti-seizure medication, the decision 

whether that person’s condition is likely 

to cause the loss of consciousness or 

loss of ability to control a CMV should 

be made on an individual basis by the 

medical examiner in consultation with 

the treating physician. Before 

certification is considered, it is 

suggested that a 6-month waiting period 

elapse from the time of the episode. 

Following the waiting period, it is 

suggested that the individual have a 

complete neurological examination. If 

the results of the examination are 

negative and anti-seizure medication is 

not required, then the driver may be 

qualified. 

In those individual cases where a 

driver had a seizure or an episode of 

loss of consciousness that resulted from 

a known medical condition (e.g., drug 

reaction, high temperature, acute 

infectious disease, dehydration, or acute 

metabolic disturbance), certification 

should be deferred until the driver has 

recovered fully from that condition, has 

no existing residual complications, and 

is not taking anti-seizure medication. 

Drivers who have a history of epilepsy/ 

seizures, off anti-seizure medication and 

seizure-free for 10 years, may be 

qualified to operate a CMV in interstate 

commerce. Interstate drivers with a 

history of a single unprovoked seizure 

may be qualified to drive a CMV in 

interstate commerce if seizure-free and 

off anti-seizure medication for a 5-year 

period or more. 

Submitting Comments 

You may submit your comments and 

material online or by fax, mail, or hand 

delivery, but please use only one of 

these means. FMCSA recommends that 

you include your name and a mailing 

address, an email address, or a phone 

number in the body of your document 

so that FMCSA can contact you if there 

are questions regarding your 

submission. To submit your comment 

online, go to http://www.regulations.gov 

and in the search box insert the docket 

number ‘‘FMCSA–2014–0382’’ and click 

the search button. When the new screen 

appears, click on the blue ‘‘Comment 

Now!’’ button on the right hand side of 

the page. On the new page, enter 

information required including the 

specific section of this document to 

which each comment applies, and 

provide a reason for each suggestion or 

recommendation. If you submit your 

comments by mail or hand delivery, 

submit them in an unbound format, no 

larger than 81⁄2 by 11 inches, suitable for 

copying and electronic filing. If you 

submit comments by mail and would 

like to know that they reached the 

facility, please enclose a stamped, selfaddressed postcard or envelope. 

We will consider all comments and 

material received during the comment 

period and may change this proposed 

rule based on your comments. FMCSA 

may issue a final rule at any time after 

the close of the comment period. 

Viewing Comments and Documents 

To view comments, as well as any 

documents mentioned in this preamble, 

To submit your comment online, go to 

http://www.regulations.gov and in the 

search box insert the docket number 

‘‘FMCSA–2014–0382’’ and click 

‘‘Search.’’ Next, click ‘‘Open Docket 

Folder’’ and you will find all documents 

and comments related to the proposed 

rulemaking. 

Summary of Applications 

Daryl Charles Anderson 

Mr. Anderson is a 61 year-old class A 

CDL holder in Michigan. He has a 

history of a seizure disorder and has 

remained seizure free since 1989. He 

takes anti-seizure medication with the 

dosage and frequency remaining the 

same since that time. If granted the 

exemption, he would like to drive a 

CMV. His physician states that he is 

supportive of Mr. Anderson receiving an 

exemption. 

Cody Allen Baker 

Mr. Baker is a 24 year-old driver in 

Michigan. He has a history of a seizure 

disorder and has remained seizure free 

for more than four years. He takes antiseizure medication with the dosage and 

frequency remaining the same since 

December 2013. If granted the 

exemption, he would like to drive a 

CMV. His physician states that he is 

supportive of Mr. Baker receiving an 

exemption. 

Ronald J. Bennett 

Mr. Bennett is a 58 year-old class B 

CDL holder in New York. He has a 

history of epilepsy and has remained 

seizure free since 2002. He takes antiseizure medication with the dosage and 

frequency remaining the same since that 

time. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. Bennett receiving an exemption. 

Don Carrol Darbyshire 

Mr. Darbyshire is a 51 year-old class 

B CDL holder in Iowa. He has a history 

of epilepsy and has remained seizure 

free since 1993. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same since that 

time. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. Darbyshire receiving an exemption. 

Monte James DeRocini 

Mr. DeRocini is a 53 year-old class A 

CDL holder in Pennsylvania. He has a 

history of a single seizure in 2011. He 

takes anti-seizure medication with the 

dosage and frequency remaining the 

same since that time. If granted the 

exemption, he would like to drive a 

CMV. His physician states that he is 

supportive of Mr. DeRocini receiving an 

exemption. 

Martin L. Ford 

Mr. Ford is a 57 year-old class C CDL 

holder in Mississippi. He has a history 

of seizures and has remained seizure 

free since 2003. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same since 

2008. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. Ford receiving an exemption. 

Glen Michael Gervais 

Mr. Gervais is a 52 year-old driver in 

Florida. He has a history of a seizure 

disorder and has remained seizure free 

since 2011. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same since that 

time. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. Gervais receiving an exemption. 

Roger Green 

Mr. Green is a 60 year-old class A 

CDL holder in Pennsylvania. He has a 

history of a seizure disorder and has 

remained seizure free since 1971. He 

takes anti-seizure medication with the 

mstockstill on DSK4VPTVN1PROD with NOTICES

19732 Federal Register / Vol. 80, No. 70 / Monday, April 13, 2015 / Notices 

dosage and frequency remaining the 

same since 2004. If granted the 

exemption, he would like to drive a 

CMV. His physician states that he is 

supportive of Mr. Green receiving an 

exemption. 

Susie B. Harvey 

Ms. Harvey is a 64 year-old class B 

CDL holder in Virginia. She has a 

history of epilepsy and has remained 

seizure free since 1985. She takes antiseizure medication with the dosage and 

frequency remaining the same since that 

time. If granted the exemption, she 

would like to drive a CMV. Her 

physician states that he is supportive of 

Ms. Harvey receiving an exemption. 

Timothy G. Huntley 

Mr. Huntley is a 40 year-old class B 

CDL holder in Maine. He has a history 

of a seizure disorder and has remained 

seizure free since 2000. He takes antiseizure medication with the dosage and 

frequency remaining the same since that 

time. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. Huntley receiving an exemption. 

Robert Isaac Keen, Jr. 

Mr. Keen is a 66 year-old driver in 

Virginia. He has a history of a seizure 

disorder and has remained seizure free 

since 2012. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same since that 

time. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. Keen receiving an exemption. 

Chance Joseph O’Mary 

Mr. O’Mary is a 29 year-old class A 

CDL holder in Alaska. He has a history 

of a seizure disorder and has remained 

seizure free since 2005. He takes antiseizure medication with the dosage and 

frequency remaining the same since that 

time. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. O’Mary receiving an exemption. 

Larry Todd Lintelman 

Mr. Lintelman is a 48 year-old class 

A CDL holder in Alaska. He has a 

history of seizures and has remained 

seizure free since 2012. He takes antiseizure medication with the dosage and 

frequency remaining the same since that 

time. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. Lintelman receiving an exemption. 

Robert D. Richter, Sr. 

Mr. Richter is a 58 year-old driver in 

Pennsylvania. He has a history of a 

seizure disorder and has remained 

seizure free since 1976. He takes antiseizure medication with the dosage and 

frequency remaining the same since that 

time. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. Richter receiving an exemption. 

Robert R. Rosebrough, Jr. 

Mr. Rosebrough is a 45 year-old class 

A CDL holder in Ohio. He has a history 

of epilepsy and has remained seizure 

free since May 2014. He takes antiseizure medication with the dosage and 

frequency remaining the same since 

November 2014. If granted the 

exemption, he would like to drive a 

CMV. His physician states that since it 

has only been nine months since his last 

event of loss of consciousness, Mr. 

Rosebrough may drive his personal 

vehicle until he has been seizure free for 

8 years. 

Michael Scott Shumake 

Mr. Shumake is a 37 year-old driver 

in Virginia. He has a history of a seizure 

disorder and has remained seizure free 

since 2000. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same since 

2001. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. Shumake receiving an exemption. 

Charles Ray Taylor 

Mr. Taylor is a 49 year-old class A 

CDL holder in Mississippi. He has a 

history of a single seizure in 2009. He 

takes anti-seizure medication with the 

dosage and frequency remaining the 

same since that time. If granted the 

exemption, he would like to drive a 

CMV. His physician states that he is 

supportive of Mr. Taylor receiving an 

exemption. 

Karin Hawley Wagasy 

Ms. Wagasy is a 58 year-old driver in 

Tennessee. She has a history of a seizure 

disorder and has remained seizure free 

since 1975. She takes anti-seizure 

medication with the dosage and 

frequency remaining the same since that 

time. If granted the exemption, she 

would like to drive a CMV. Her 

physician states that he is supportive of 

Ms. Wagasy receiving an exemption. 

Trever A. Williams 

Mr. Williams is a 44 year-old class A 

CDL holder in Minnesota. He has a 

history of a single seizure in 1983 which 

occurred postoperatively, after a 

surgical procedure to remove a foreign 

body from his head. He takes antiseizure medication with the dosage and 

frequency remaining the same since 

2006. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. Williams receiving an exemption. 

Request for Comments 

In accordance with 49 U.S.C. 31315 

and 31136(e), FMCSA requests public 

comment from all interested persons on 

the exemption applications described in 

this notice. We will consider all 

comments received before the close of 

business on the closing date indicated 

earlier in the notice. 

Issued on: April 7, 2015. 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2015–08392 Filed 4–10–15; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[FMCSA Docket No. FMCSA–2014–0312] 

Qualification of Drivers; Exemption 

Applications; Diabetes Mellitus 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), DOT. 

ACTION: Notice of final disposition. 

SUMMARY: FMCSA confirms its decision 

to exempt 69 individuals from its rule 

prohibiting persons with insulin-treated 

diabetes mellitus (ITDM) from operating 

commercial motor vehicles (CMVs) in 

interstate commerce. The exemptions 

enable these individuals to operate 

CMVs in interstate commerce. 

DATES: The exemptions were effective 

on February 24, 2015. The exemptions 

expire on February 24, 2017. 

FOR FURTHER INFORMATION CONTACT: 

Charles A. Horan, III, Director, Carrier, 

Driver and Vehicle Safety Standards, 

(202) 366–4001, fmcsamedical@ dot.gov, 

FMCSA, Room W64–224, Department of 

Transportation, 1200 New Jersey 

Avenue SE., Washington, DC 20590– 

0001. Office hours are from 8:30 a.m. to 

5 p.m., Monday through Friday, except 

Federal holidays. 

SUPPLEMENTARY INFORMATION: 

I. Electronic Access 

You may see all the comments online 

through the Federal Document 

Management System (FDMS) at: http:// 

www.regulations.gov. 

Docket: For access to the docket to 

read background documents or 

mstockstill on DSK4VPTVN1PROD with NOTICES